Anyplex™ BRAF V600E Real-time Detection is designed to detect BRAF mutation (V600E) characteristic of papillary thyroid carcinoma from samples of thyroid tissue, fine needle aspiration biopsy (FNAB), H&E slides and paraffin-embedded tissues. Based on Seegene’s proprietary DPO™ technologies, this assay performs on real-time PCR instrument and detection limits of 1% BRAF gene mutation within 2 hours after extraction.
Features
-
Wide range of specimens
Wide range of applicable specimens
-
Detection limit 1%
Detection limit : 1% of BRAF gene mutation
-
Multiplex real-time PCR
PCR with high sensitivity and specificity by applying DPO™ technology
-
Whole process validation
Whole process validation from extraction to PCR by whole process control
-
UDG system
Utilization of the UDG system to prevent carry-over contamination
-
Automatic data analyzer
Automated data interpretation and LIS interlocking with Seegene Viewer
-
Analytes
Anyplex™
BRAF V600E Real-time Detection
- V600E
- Internal Control (IC)
-
Specimens
- Thyroid tissues
- Thyroid fine needle aspiration biopsy (FNAB)
- Formalin fixed paraffin embedded (FFPE) thyroid tissues
- Hematoxylin and eosin (H&E) thyroid slide
- Liquid based cytology specimen (Thinprep®)
-
Ordering Information
ProductCat No. / SizeAnyplex™ BRAF V600E Real-time Detection
Result
The results show positive results for BRAF V600E using the CFX96 real-time PCR instrument.
